Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

NCT04851717

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of California Davis Children's Hospital Sacramento, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • University of Minnesota Masonic Children's Hospital Minneapolis, Minnesota, United States
View Trial Details
Active, Not Recruiting

PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

NCT03817320

Conditions
ALL, Childhood, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

NCT04541212

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Centre Hospitalier de l'université de Montréal (CHUM) Montreal, Quebec, Canada
  • CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital Montreal, Quebec, Canada
  • CIUSSS de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • CIUSSS du Centre-Ouest de l'Île de Montréal - Jewish General Hospital Montreal, Quebec, Canada
View Trial Details
Active, Not Recruiting

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

NCT04515238

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Hamatologische/Onkologische Gemeinschaftspraxis Augsburg, Germany
  • Universitätsklinik Köln Cologne, Germany
  • Onkologische Schwerpunktpraxis Esslingen am Neckar, Germany
  • Evangelische Krankenhaus Hamm Hamm, Germany
View Trial Details

Related conditions